JAGUAR HEALTH, INC. COMMON STOCK WARRANTJaguar Health, Inc. • September 4th, 2018 • Pharmaceutical preparations • Delaware
Holder is an “Accredited Investor” as that term is defined in Regulation D promulgated by the Securities and Exchange Commission. The term “Accredited Investor” under Regulation D refers to:
201 MISSION SAN FRANCISCO, CALIFORNIA OFFICE LEASE AGREEMENT BETWEEN CA-MISSION STREET LIMITED PARTNERSHIP, a Delaware limited partnership (“LANDLORD”) AND JAGUAR HEALTH, INC., a Delaware corporation (“TENANT”) SUITE 2375Office Lease Agreement • September 4th, 2018 • Jaguar Health, Inc. • Pharmaceutical preparations • California
THIS OFFICE LEASE AGREEMENT (this “Lease”) is entered into as of August 30, 2018 (the “Effective Date”), by and between CA-MISSION STREET LIMITED PARTNERSHIP, a Delaware limited partnership (“Landlord”) and JAGUAR HEALTH, INC., a Delaware corporation (“Tenant”).
LANDLORD LETTER OF CREDIT & WARRANT ISSUANCE AGREEMENTWarrant Issuance Agreement • September 4th, 2018 • Jaguar Health, Inc. • Pharmaceutical preparations • California
THIS LANDLORD LETTER OF CREDIT & WARRANT ISSUANCE AGREEMENT (the “Agreement”) is deemed to be effective as of August 28, 2018 (the “Effective Date”), by and among Jaguar Health, Inc., a Delaware corporation (the “Company”), and the undersigned letter of credit facilitator identified on the signature page hereto (the “LC Facilitator”).
